Paul K Newton
Overview
Explore the profile of Paul K Newton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahmoodifar S, Pangal D, Neman J, Zada G, Mason J, Salhia B, et al.
J Neurooncol
. 2024 Apr;
167(3):501-508.
PMID: 38563856
Objective: Brain metastases (BM) are associated with poor prognosis and increased mortality rates, making them a significant clinical challenge. Studying BMs can aid in improving early detection and monitoring. Systematic...
2.
Mahmoodifar S, Pangal D, Cardinal T, Craig D, Simon T, Tew B, et al.
J Neurooncol
. 2022 Oct;
160(1):241-251.
PMID: 36245013
Purpose: Brain metastases (BM) remain a significant cause of morbidity and mortality in breast cancer (BC) patients. Specific factors promoting the process of BM and predilection for selected neuro-anatomical regions...
3.
Mason J, Hasnain Z, Miranda G, Gill K, Djaladat H, Desai M, et al.
Eur Urol Open Sci
. 2021 Oct;
32:8-18.
PMID: 34667954
Background: Bladder cancer (BCa), the sixth commonest cancer in the USA, is highly lethal when metastatic. Spatial and temporal patterns of patient-specific metastatic spread are deemed random and unpredictable. Whether...
4.
Dua R, Ma Y, Newton P
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34207564
We investigate the robustness of adaptive chemotherapy schedules over repeated cycles and a wide range of tumor sizes. Using a non-stationary stochastic three-component fitness-dependent Moran process model (to track frequencies),...
5.
Nilanon T, Nocera L, Martin A, Kolatkar A, May M, Hasnain Z, et al.
JCO Clin Cancer Inform
. 2020 Sep;
4:839-853.
PMID: 32970482
Purpose: Unplanned health care encounters (UHEs) such as emergency room visits can occur commonly during cancer chemotherapy treatments. Patients at an increased risk of UHEs are typically identified by clinicians...
6.
Hasnain Z, Nilanon T, Li M, Mejia A, Kolatkar A, Nocera L, et al.
JCO Clin Cancer Inform
. 2020 Jun;
4:583-601.
PMID: 32598179
Purpose: Performance status (PS) is a key factor in oncologic decision making, but conventional scales used to measure PS vary among observers. Consumer-grade biometric sensors have previously been identified as...
7.
Hasnain Z, Fraser A, Georgess D, Choi A, Macklin P, Bader J, et al.
Bioinformatics
. 2020 Feb;
36(10):3292-3294.
PMID: 32091578
Summary: Organoid model systems recapitulate key features of mammalian tissues and enable high throughput experiments. However, the impact of these experiments may be limited by manual, non-standardized, static or qualitative...
8.
West J, You L, Zhang J, Gatenby R, Brown J, Newton P, et al.
Cancer Res
. 2020 Jan;
80(7):1578-1589.
PMID: 31948939
A new ecologically inspired paradigm in cancer treatment known as "adaptive therapy" capitalizes on competitive interactions between drug-sensitive and drug-resistant subclones. The goal of adaptive therapy is to maintain a...
9.
Fujii T, Mason J, Chen A, Kuhn P, Woodward W, Tripathy D, et al.
Oncologist
. 2019 Apr;
24(10):1322-1330.
PMID: 30952823
Background: Inflammatory breast cancer (IBC) is a rare yet aggressive variant of breast cancer with a high recurrence rate. We hypothesized that patterns of metastasis differ between IBC and non-IBC....
10.
Hasnain Z, Mason J, Gill K, Miranda G, Gill I, Kuhn P, et al.
PLoS One
. 2019 Feb;
14(2):e0210976.
PMID: 30785915
Currently in patients with bladder cancer, various clinical evaluations (imaging, operative findings at transurethral resection and radical cystectomy, pathology) are collectively used to determine disease status and prognosis, and recommend...